Maxwell TM - Search Results

1

Chromosomal clues to the development of prostate tumors.

Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. Brothman AR, et al. Among authors: maxwell tm. Prostate. 1999 Mar 1;38(4):303-12. doi: 10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.0.co;2-e. Prostate. 1999. PMID: 10075010 Review.

2

Hypermethylation of the caveolin-1 gene promoter in prostate cancer.

Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, Brothman AR. Cui J, et al. Prostate. 2001 Feb 15;46(3):249-56. doi: 10.1002/1097-0045(20010215)46:3<249::aid-pros1030>3.0.co;2-#. Prostate. 2001. PMID: 11170154

3

Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization.

Cui J, Deubler DA, Rohr LR, Zhu XL, Maxwell TM, Changus JE, Brothman AR. Cui J, et al. Among authors: maxwell tm. Cancer Genet Cytogenet. 1998 Nov;107(1):51-60. doi: 10.1016/s0165-4608(98)00074-0. Cancer Genet Cytogenet. 1998. PMID: 9809035

4

A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.

Dai Q, Deubler DA, Maxwell TM, Zhu XL, Cui J, Rohr LR, Stephenson RA, Brothman AR. Dai Q, et al. Among authors: maxwell tm. Genomics. 2001 Feb 1;71(3):324-9. doi: 10.1006/geno.2000.6436. Genomics. 2001. PMID: 11170749

5

Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?

Brothman AR, Swanson G, Maxwell TM, Cui J, Murphy KJ, Herrick J, Speights VO, Isaac J, Rohr LR. Brothman AR, et al. Among authors: maxwell tm. Cancer Genet Cytogenet. 2005 Jan 1;156(1):31-6. doi: 10.1016/j.cancergencyto.2004.04.004. Cancer Genet Cytogenet. 2005. PMID: 15588853

6

Array comparative genomic hybridization for genetic evaluation of fetal loss between 10 and 20 weeks of gestation.

Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Warren JE, et al. Among authors: maxwell tm. Obstet Gynecol. 2009 Nov;114(5):1093-1102. doi: 10.1097/AOG.0b013e3181bc6ab0. Obstet Gynecol. 2009. PMID: 20168112

7

Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics.

Pettus JA, Cowley BC, Maxwell T, Milash B, Stephenson RA, Rohr LR, Hoff C, Brothman AR. Pettus JA, et al. Cancer Genet Cytogenet. 2004 Oct 15;154(2):110-8. doi: 10.1016/j.cancergencyto.2004.05.019. Cancer Genet Cytogenet. 2004. PMID: 15474145

8

A new genomic mechanism leading to cri-du-chat syndrome.

South ST, Swensen JJ, Maxwell T, Rope A, Brothman AR, Chen Z. South ST, et al. Am J Med Genet A. 2006 Dec 15;140(24):2714-20. doi: 10.1002/ajmg.a.31496. Am J Med Genet A. 2006. PMID: 17103439

9

An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.

Morgan MJ, Thorburn J, Thomas L, Maxwell T, Brothman AR, Thorburn A. Morgan MJ, et al. Cell Death Differ. 2001 Jul;8(7):696-705. doi: 10.1038/sj.cdd.4400866. Cell Death Differ. 2001. PMID: 11464214

10

Mandibulofacial dysostosis in a patient with a de novo 2;17 translocation that disrupts the HOXD gene cluster.

Stevenson DA, Bleyl SB, Maxwell T, Brothman AR, South ST. Stevenson DA, et al. Am J Med Genet A. 2007 May 15;143A(10):1053-9. doi: 10.1002/ajmg.a.31715. Am J Med Genet A. 2007. PMID: 17431905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page